by Viara Staneva | Feb 18, 2020 | news
Drug pricing remains a hot topic, and a new report offers some reasons: The most expensive drugs sold at pharmacies can cost as much as a luxury car—every month. And GoodRx’s latest ranking of the country’s costliest drugs include brands new and old....
by Viara Staneva | Sep 25, 2019 | news
French pharma Servier begins trial today, as the company stands accused of manslaughter and deceit over a diabetes weight loss drug linked to as many as 2,000 deaths. The drug, Mediator (benfluorex), was pulled out of French pharmacies in 2009 after 33 years on the...
by Viara Staneva | Jul 19, 2019 | news
Тhe BACE theory of controlling Alzheimer’s died with failed pivotal projects at Merck, Eli Lilly and their partners at AstraZeneca. Now Amgen and Novartis have come along to bulldoze it under a mound of safety threats — leaving only Biogen and Eisai to carry on with a...
by Viara Staneva | Jun 17, 2019 | news
Two new gene therapies—from Novartis and Spark Therapeutics—carry price tags higher than any other drugs in the U.S., elbowing aside the brands we’ve seen at the top for years, a GoodRx analysis shows. And with drugmakers doubling down in rare diseases, the...
by Viara Staneva | May 7, 2019 | news
Pharma hasn’t exactly won accolades for its speed in adopting new artificial intelligence and machine learning technologies. But while it’s drawn flak for that digital lag, it’s got good reason to proceed with caution where AI is concerned, one expert says. ...
